tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market

Halozyme (HALO) Income Statement

Compare
1,129 Followers

Halozyme Income Statement

Last quarter (Q3 2025), Halozyme's total revenue was $354.26M, an increase of 22.12% from the same quarter last year. In Q3, Halozyme's net income was $175.22M. See Halozyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.02B$ 829.25M$ 660.12M$ 443.31M$ 267.59M
Gross Profit
$ 855.91M$ 636.89M$ 520.81M$ 361.90M$ 224.23M
Operating Expenses
$ 304.43M$ 299.32M$ 253.28M$ 86.00M$ 79.97M
Depreciation and Amortization
$ 81.31M$ 84.86M$ 49.64M$ 3.00M$ 3.28M
EBITDA
$ 656.54M$ 451.95M$ 315.51M$ 259.04M$ 152.96M
Operating Income
$ 551.48M$ 337.57M$ 267.53M$ 275.90M$ 144.25M
Other Income/Expenses
$ 5.66M$ 10.76M$ -18.61M$ -27.38M$ -14.95M
Pretax Income
$ 557.13M$ 348.33M$ 248.92M$ 248.52M$ 129.30M
Net Income
$ 444.09M$ 281.59M$ 202.13M$ 402.71M$ 129.09M
Per Share Metrics
Basic EPS
$ 3.50$ 2.13$ 1.48$ 2.86$ 0.95
Diluted EPS
$ 3.43$ 2.10$ 1.44$ 2.74$ 0.91
Weighted Average Shares Outstanding
126.83M 131.93M 136.84M 140.65M 136.21M
Weighted Average Shares Outstanding (Diluted)
129.42M 134.20M 140.61M 146.80M 141.46M
Currency in USD

Halozyme Earnings and Revenue History